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There is increasing evidence that obesity is related to asthma development and severity.
However, it is largely unknown whether weight reduction can influence asthma manage-
ment, especially in children.
Objective
To determine the effects of a multifactorial weight reduction intervention on asthma man-
agement in overweight/obese children with (a high risk of developing) asthma.
Methods
An 18-month weight-reduction randomized controlled trial was conducted in 87 children
with overweight/obesity and asthma. Every six months, measurements of anthropometry,
lung function, lifestyle parameters and inflammatory markers were assessed. Analyses
were performed with linear mixed models for longitudinal analyses.
Results
After 18 months, the body mass index-standard deviation score decreased by -0.14±0.29
points (p<0.01) in the intervention group and -0.12±0.34 points (p<0.01) in the control
group. This change over time did not differ between groups (p>0.05). Asthma features
(including asthma control and asthma-related quality of life) and lung function indices (static
and dynamic) improved significantly over time in both groups. The FVC% predicted
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improved over time by 10.1 ± 8.7% in the intervention group (p<0.001), which was signifi-
cantly greater than the 6.1 ± 8.4% in the control group (p<0.05).
Conclusions & clinical relevance
Clinically relevant improvements in body weight, lung function and asthma features were
found in both the intervention and control group, although some effects were more pro-
nounced in the intervention group (FVC, asthma control, and quality of life). This implies




The high childhood obesity prevalence is a major public health problem [1]. A high body mass
index (BMI) increases the risk of developing asthma. Prospective studies suggested that a high
BMI precedes asthma symptoms [2]. Moreover, a dose-response effect of BMI on asthma
symptoms has been detected [3]. In comparison to their lean counterparts, the obese-asthmatic
population is characterised by decreased asthma control, high medication use, and frequent
asthma-related hospital admissions [4–6]. As obese children often become obese adults, it is
necessary to tackle obesity early in life [7].
It is largely unknown whether weight reduction in overweight/obese children can improve
asthma features (symptoms, lung function, amount of medication) in patients with already
established disease, or can prevent the development of asthma in children at risk (e.g. with the
combination of obesity and a first degree family member with asthma) [8, 9]. Most weight
reduction studies in asthmatic patients have been conducted in adults [8, 9]. After weight
reduction, improvements in lung function, asthma symptoms, asthma control and use of res-
cue medication have been found. However, most studies have sample sizes< 40 participants
and weight loss was frequently achieved with bariatric surgery [8]. In children, a handful of
studies have been performed [10–13]. These studies provided some interesting evidence that
weight loss can induce beneficial changes in childhood asthma outcomes, such as asthma-
related quality of life (QOL), asthma control, and improvements in lung function [10–13].
Although these first results are promising, the majority of these paediatric studies had small
sample sizes (e.g.< 40 subjects) and/or no control group. Therefore, a well-powered random-
ized controlled trial (RCT) with a long term follow-up is needed to validate these findings.
In addition to methodological issues, the mechanisms underlying the increased risk of
asthma in overweight/obese children, and/or the improvement in asthma features following
weight loss, are poorly understood. Obesity causes mechanical, metabolic, and immunological
changes that may affect the respiratory system [9]. Both mechanical changes (including
improvements in chest wall compliance as a result of less mass loading of fat in and around the
chest wall) and inflammatory changes (including increases in adiponectin, reductions in c-
reactive protein and leptin) have been proposed to bring about improvement in asthma after
weight reduction [9, 10, 14, 15]. Nevertheless, limited weight reduction studies in asthmatic
children investigated the outcome parameters of both pathways [8, 10].
The primary aim of this study was to investigate the effects of a longitudinal, multidisciplin-
ary, RCT directed towards weight reduction in overweight/obese children with (a high risk of
developing) asthma. Our primary outcomes included the forced expiratory volume in 1 second
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(FEV1% predicted) and the BMI-standard deviation score (SDS). Secondary outcomes were
other asthma features (asthma control, medication, asthma related QOL), lifestyle parameters




Children were included in a multifactorial RCT entitled MIKADO (clinicaltrial.gov
NCT00998413) [16]. Generalised block randomization with 10 participants per block, was per-
formed by a computer program, with an allocation ratio of 1:1 [16]. Because this was a lifestyle
study, blinding was not possible. The study duration was 18 months and regular measurements
were performed every six months (T0, T6, T12, T18) (Fig 1). The control group received the
usual care according to the international GINA (Global Initiative For Asthma) criteria and the
Dutch national standard [17, 18]. All caregivers and children aged 12 years or older provided
written informed consent prior to inclusion. The study was approved by the Medical Ethics
Committee of Maastricht University Medical Centre (MEC 09-2-088).
Study sample
Overweight/obese children (according to Dutch reference charts [19]) aged 6 to 16 were
selected with either a clear clinical diagnosis of asthma, or with a high risk of developing
asthma (because of the combination of overweight/obesity and at least one first-grade family
member with asthma). Children with asthma fulfilled the GINA criteria for a diagnosis of
asthma, with presence of asthma symptoms, bronchial hyperresponsiveness, and airway revers-
ibility to a beta-2 agonist [17, 18] (Fig 1).
The intervention
The control group received the usual care as stated above. In addition to the usual care, the
intervention group received an 18-month multifactorial weight intervention consisting of 18
lifestyle sessions (including dietary advices and cognitive behavioural therapy), 10 parental ses-
sions, 8 individual sessions, and regular sport sessions, at the MUMC+. The intervention was
divided into an initial phase (months 0–6) and a follow-up phase (months 7–18). During the
first six months the main themes of the lifestyle, parental and individual sessions were aware-
ness of the obesity problem, consideration of new healthy behaviours and decision-making
regarding new healthy behaviours. In the last 12 months of the programme children learned
how to preserve their new behaviours and how to avoid reverting to old behaviours. The inter-
vention was based on the ‘Health counselling model’. Sport sessions (60 minutes per session)
consisted of regular group exercises (twice a week during the initial phase, and three times a
month plus encouraging participation in an individual sport activity once a week, during the
follow-up phase). A detailed description of the intervention is provided in a previous publica-
tion of the study protocol (S1 File. Study protocol) [16].
Measurements
All outcome measures have been described previously in detail [16]. A summary is given
below.
Primary outcome variables. The FEV1% predicted was obtained via maximal expiratory
flow volume curves, measured with a spirometer (ZANMessgerate, Oberthulba, Germany)
according to the American Thoracic Society/European Respiratory Society (ATS/ERS)
Weight Loss in Overweight Children with Asthma
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Fig 1. Consort flow diagram. * Two participants discontinued the sport sessions during the follow-up phase of the intervention due
to membership of an organised sports association, but did continue to attend the lifestyle, individual and parental sessions. Those
participants were included in the per protocol analysis.
doi:10.1371/journal.pone.0157158.g001
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guidelines with predictive values of Zapletal et al., as described in detail previously [16, 20, 21].
Weight and height were measured twice and averaged to calculate the BMI (weight/height2).
BMI-SDS was based on the reference charts of the Dutch fourth Nationwide Growth Study
[22]. Overweight was defined as a BMI-SDS of1.1 and<2.3, and obesity as a BMI-SDS of
2.3 [23].
Secondary outcome variables. Secondary outcome variables included asthma control [24,
25], asthma-related QOL [26], exercise-induced-bronchoconstriction (EIB), forced vital capac-
ity (FVC% predicted), static lung function indices [20], and leptin and adiponectin serum con-
centration. Asthma was defined as uncontrolled if participants had a childhood Asthma
Control Test (c-ACT) score of19 [27]. EIB was measured as the difference in FEV1 before
and 10 and 30 minutes after a maximal ergometer test. Static lung function indices were deter-
mined by body plethysmography (Viasys, Hoechberg, Germany) according to the ATS/ERS
guidelines [20]. Non-fasting serum concentrations of leptin and adiponectin were determined
by using a commercially available enzyme-linked immunosorbent assay (ELISA) (DY398 Duo-
set, R&D Systems, Minneapolis, USA) and radioimmunoassay (RIA) (HADP-61HK, Millicore
corporation, Billerica, USA). All samples underwent duplicate testing.
Baseline and lifestyle. Other relevant outcome variables included comorbidities of asthma
and obesity, step count, aerobic capacity (VO2peak% predicted) [28], dietary intake and atopic
status.
Step count was defined as the average step count per day measured over the course of seven
days by a tri-axial accelerometer (Yamax EX510 Power Walker, Yamax, Tokyo, Japan). A max-
imal incremental ergometer test was used to determine maximum aerobic capacity (VO2peak)
with predicted values of Bongers et al [28]. Dietary intake was measured by means of three-day
food records. Dietary intake was ranked on quality (on a scale from zero to 16) based on
amount of principal meals, fruit consumption, unhealthy snacks and healthy milk consump-
tion. The Dutch guidelines for healthy paediatric dietary intake were used as a template for this
ranking scale which was developed by our multidisciplinary team [29]. Atopy was defined as
an IgE serum concentration of0.35 kU/L for a specific mixture for inhalant allergens (Pha-
diatop test, Pharmacia, Uppsala, Sweden).
Statistical analysis
All data were assessed for normality. The power analysis was described previously [16]. Results
are presented as mean ± SD unless stated otherwise. Loss to follow up was defined as discontin-
uation of the measurements, regardless of completion of the intervention (Fig 1). Non-compli-
ance was defined as discontinuation of the intervention program, regardless of completion of
the measurements. Participants who were lost to follow up were considered missing at random,
as loss to follow up status (yes/no) was not associated with the most important baseline charac-
teristics, and change in BMI-SDS and FEV1% predicted.
For all analyses, linear mixed model analysis techniques were used, as this technique cor-
rects for the correlation with individuals in groups, which occurs in repeated-measures RCT
designs. Another advantage of this technique is that it obviously accounts for missing values, in
case data are missing at random. For the primary analysis, two linear mixed models were devel-
oped with both FEV1% predicted and BMI-SDS as dependent factors. Both intention to treat
(with all participants who completed the measurements) and per-protocol analyses (with only
participants who continued the intervention) were performed. Results are shown for intention
to treat analyses, unless stated otherwise. An extensive description of all statistical models is
provided in the supporting material (S2 File. Statistical analyses). A CONSORT statement is
provided in the supporting material (S3 File. CONSORT statement).
Weight Loss in Overweight Children with Asthma
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Results
Recruitment and participant flow
Eighty-seven children were eligible and were randomized into the control group (n = 44) or
intervention group (n = 43) (Fig 1). At 18 months, 39 patients were still followed up in the con-
trol group, and 35 patients in the intervention group. The study was performed between Sep-
tember 2011 and October 2013.
The presence at sport, group, parental and individual intervention sessions was good, aver-
aging 71%, 65%, 63% and 68%, respectively. The average heart rate for each sport session was
149 ± 9 beats per minute, which correspondents to 79% of maximum heart rate. In total, 24
participants (56%) did not complete the intervention (Fig 1). The majority of the discontinuers
(63%) stopped during the initial phase of the intervention.
In the control group, 29 participants reported that they received professional help to facili-
tate weight reduction during the 18-month study period (e.g. help of a dietician, a weight
reduction consultant, specialised obesity care in a hospital, other weight reduction pro-
grammes, or online weight reduction advice).
Baseline characteristics
Baseline characteristics are shown in Table 1. No relevant differences between intervention and
control group were observed. In total, 78% of the children had asthma, half of the children
were classified as obese, and 43% of the population used inhaled corticosteroids (ICS). Addi-
tional baseline characteristics are provided in the supporting material (S1 Table. Additional
baseline characteristics).
Primary research question: FEV1 and BMI-SDS (Fig 2)
There was no effect of group allocation on the decrease in BMI-SDS, either in terms of the
intention to treat (p = 0.84) or per protocol analysis (Fig 2A, p = 0.65). BMI-SDS decreased
after the 18-month period by -0.14 ± 0.29 points (Fig 2A, p<0.01) in the intervention group,
and -0.12 ± 0.34 points (Fig 2A, p<0.01) in the control group. The changes over time in
FEV1% predicted were not significantly different between the intervention and control group
(Fig 2B, p0.05). FEV1 improved significantly after 18 months from 90.5 ± 12.5 to 99.7 ± 11.0
(Fig 2B, p<0.05) % predicted in the intervention group, and from 89.3 ± 17.1 to 95.1 ± 16.6
(Fig 2B, p<0.05) % predicted in the control group.
Secondary research question: other asthma parameters (Figs 2, 3 and 4)
The improvement in FVC% predicted was significantly greater in the intervention group com-
pared to the control group (Fig 2C, p<0.05). None of the changes in other lung function indi-
ces differed between the intervention and control group (Figs 2D, 3A–3C and 4B, p>0.05).
FVC% predicted improved over time by 10.1 ± 8.7% in the intervention group (Fig 2C,
p<0.001) and 6.1 ± 8.4% in the control group (Fig 2C, p<0.05). In the intervention group,
ERV% predicted improved by 12.0 ± 20.5% after 18 months (Fig 3A, p<0.01), and TLC% pre-
dicted by 4.0 ± 8.8% (Fig 3B, p<0.05). FEV1/FVC% predicted, and the degree of EIB remained
unchanged during 18 months in the intervention and control group (Figs 2D and 4B, p>0.05).
Changes over time in asthma control, and the number of patients who used medication
(either SABA or ICS) were not statistically different between intervention and control group
(Figs 3C, 4C and 4D, p>0.05). PAQLQ improved slightly more in the intervention group than
the control group, although the improvement was not significantly different among the groups
(Fig 3D, p = 0.06). PAQLQ significantly improved by an average of 0.48 ± 0.72 points
Weight Loss in Overweight Children with Asthma
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(p<0.001) in children with asthma in the intervention group. This is a clinically important dif-
ference, as an increase of 0.42 is considered clinically relevant [30]. The (c)-ACT score
improved significantly in asthmatic children in the intervention group during the course of 18
months (Fig 3C, p<0.05).
No between and within group changes in inflammatory parameters were observed during
the 18-month period. Adiponectin levels decreased from (mean (SD)) 11.20 (4.62) to 10.93
(4.72) ng/ml in the intervention group and from 12.02 (3.68) to 11.95 (3.82) ng/ml in the con-
trol group (p>0.05 for between and within group changes). Similar findings were found for
leptin (Fig 4A, p>0.05).
Table 1. Baseline characteristics.
Total group (n = 87) Intervention group (n = 43) Control group (n = 44)
Baseline characteristics
Age in years, median (IQR) 12.2 (3.5) 12.3 (14.5) 11.9 (2.5)
Males, n/N* (% male) 53/87 (61) 26/43 (61) 27/44 (61)
Parents with a low education level, n/N* (%) 30/87 (34) 21/43 (49) 9/44 (20)
Average parental BMI, median (IQR) 27.7 (6.6) 26.9 (6.8) 28.4 (6.2)
Anthropometrics
BMI in kg/m2, median (IQR) 25.2 (5.3) 25.0 (6.6) 25.2 (5.1)
BMI-SDS, mean (SD) 2.34 (0.55) 2.37 (0.58) 2.32 (0.52)
Obese children (BMI-SDS2.3), n/N* (%) 45/87 (52) 23/43 (53) 22/44 (50)
Skin fold thickness in cm, median (IQR) 129.8 (59.0) 125.0 (75.5) 130.0 (45.5)
Waist circumference in cm, median (IQR) 92.9 (16.1) 90.5 (19.5) 94.0 (10.4)
Asthma features
Diagnosed asthma, n/N* (%) 68/87 (78) 32/43 (74) 36/44 (82)
Atopic, n/N* (%) 16/67 (24) 9/34 (27) 7/33 (21)
FEV1 in % predicted, mean (SD) 90.0 (15.2) 90.4 (13.6) 89.7 (16.8)
FVC in % predicted, mean (SD) 93.9 (11.4) 93.8 (10.1) 94.0 (12.7)
FEV1 /FVC in %, mean (SD) 80.3 (8.5) 80.6 (7.6) 80.1 (9.4)
ERV in % predicted, mean (SD) 79.2 (25.3) 75.9 (26.2) 82.1 (24.5)
PC20 histamine, median (IQR) 1.81 (4.92) 2.08 (4.31) 1.40 (5.57)
Uncontrolled asthma according to (c)-ACT, n/N* (%)† 23/68 (34) 11/32 (34) 12/36 (33)
PAQLQ, median (IQR) † 6.26 (0.87) 6.17 (0.72) 6.30 (1.35)
Use of SABA, n/N* (%)† 29/68 (43) 14/32 (44) 15/36 (42)
Use of more than one dose equivalent SABA, n/N* (%)†, ƍ 16/68 (24) 11/32 (34) 5/36 (14)
Use of ICS, n/N* (%)† 29/68 (43) 10/32 (31) 19/36 (53)
Use of more than one dose equivalent ICS, n/N* (%)†,ƍ 12/68 (18) 3/32 (9) 9/36 (25)
Inﬂammatory parameters
FeNO in ppb, median (IQR) 15.8 (30.7) 15.0 (34.0) 16.8 (29.5)
Serum leptin in ng/ml, median (IQR) 1.83 (2.45) 1.83 (2.40) 1.83 (2.49)
Serum adiponectin in mg/mL, mean (SD) 11.6 (4.2) 11.2 (4.6) 12.0 (3.7)
* n/N: Number of participants with a positive outcome for this parameter/Number of participants measured. Numbers (N) may not add up to 87, 43 and 44,
respectively due to missing values or, in case of asthma related parameters (†), as these parameters were only demonstrated for asthmatic participants
(not for participants with a high risk of developing asthma).
ƍ Dose equivalents were calculated according to standard dosages of SABA and ICS, as described previously [16].
Abbreviations: (c)-ACT: (childhood) asthma control test, BMI: body mass index, BMI-SDS: body mass index standard deviation score, ERV: expiratory
reserve volume, FeNO: fraction of exhaled nitric oxide, FEV1: forced expiratory volume in 1 second, FVC: forced vital capacity, ICS: inhaled
corticosteroids, IQR: inter quartile range, PAQLQ: paediatric asthma quality of life questionnaire, PC20 histamine: histamine concentration that led to a
drop of 20% in FEV1, SABA: short-acting beta-2 agonists, SD: standard deviation.
doi:10.1371/journal.pone.0157158.t001
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Lifestyle parameters in the intervention and control group
None of the trends in lifestyle parameters were significantly different between intervention and
control group (for all parameters, p>0.05) (S1 Fig Additional Figures). Aerobic fitness
(VO2peak% predicted) was the only lifestyle parameter which significantly changed over time
(p<0.01) in the intervention group, though it was not significantly different from the control
group.
Discussion
The most important finding of this study was that deteriorations in body weight/BMI-SDS and
lung function in children with overweight/obesity and (a high risk of developing) asthma can
be curtailed and to some extent reversed. We not only found significant decreases in BMI-SDS,
Fig 2. Changes over time in: a) BMI-SDS, b) FEV1%predicted, c) FVC%predicted, d), FEV1/FVC (in %) §. Data are presented as mean
(SEM). *: Significant difference over time in the intervention group (p<0.05). †: Significant difference over time in the control group (p<0.05). ‡:
Significant difference between intervention and control group over time (p<0.05). §: Intention to treat analyses are presented. Abbreviations:
BMI-SDS: body mass index standard deviation score, FEV1%predicted: forced expiratory volume in 1 second in %predicted, FVC: forced vital
capacity in %predicted.
doi:10.1371/journal.pone.0157158.g002
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but also observed clinically relevant improvements in several lung function indices (FEV1,
FVC, ERV, TLC), asthma control, aerobic fitness, and asthma quality of life (PAQLQ). How-
ever, in general, improvements were no greater in the intervention than in the control group
with some exceptions. FVC% predicted improved by significantly more in the intervention
group compared to the control group, and improvements in asthma control and PAQLQ were
more pronounced in the intervention group than in the control group. A considerable number
of children/parents in the control group (receiving ‘the usual care’) wished to improve their
body weight, lung function and/or asthma outcomes (which was one of the motivations to par-
ticipate in the study), and sought the extra professional help of a dietician, a weight reduction
Fig 3. Changes over time in: a) ERV%predicted, b) TLC%predicted, c) (c)- ACT ll, d) PAQLQ ll §. Data are presented as mean (SEM). *:
Significant difference over time in the intervention group (p<0.05). †: Significant difference over time in the control group (p<0.05). ‡: Significant
difference between intervention and control group over time (p<0.05). §: Intention to treat analyses are presented. ll: Only subjects with an asthma
diagnosis are shown. Abbreviations: (c)-ACT: (childhood) asthma control test (score can range between 0 = not well controlled to 27 = well
controlled asthma), ERV%predicted: expiratory reserve volume in % predicted, PAQLQ, paediatric asthma quality of life questionnaire (with 23
questions in three domains (symptoms, activity limitation and emotional function), all questions can be scored on a 7-point scale (7 = not bothered
at all—1 = extremely bothered). The overall PAQLQ score is the mean of all 23 responses.), TLC%predicted: total lung capacity in % predicted.
doi:10.1371/journal.pone.0157158.g003
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consultant, or online weight reduction advice during the study. Such behaviour is difficult to
prevent in a real-life study such as this.
The improvements in BMI in this study were in line with data of a recent meta-analysis of
paediatric weight reduction programs by Waters et al, showing the effects of weight reduction
programmes on BMI/BMIz of -0.15kg/m2 (95% CI: -0.21 to -0.09) [31]. Some studies in
asthma described weight loss with effects ranging from 0.2 BMI-SDS points to an impressive
weight reduction of 6 kg/m2 in BMI in one study [10–13, 15]. The results of the latter study
could be slightly distorted as only per protocol analyses were shown and no control group was
used [10]. Unfortunately, we did not achieve more weight reduction in the intervention than
the control group of our study for reasons discussed below.
Fig 4. Changes over time in: a) Degree of EIB (in percent fall of FEV1 after exercise), b) Leptin concentration (in ng/ml), c) % of
participants using SABA ll, d) % of participants using ICS ll §. Data are presented as mean (SEM). *: Significant difference over time in the
intervention group (p<0.05). †: Significant difference over time in the control group (p<0.05). ‡: Significant difference between intervention and
control group over time (p<0.05). §: Intention to treat analyses are presented. ll: Only subjects with an asthma diagnosis are shown. Abbreviations:
EIB: exercise induced bronchoconstriction (in percent fall of FEV1 after exercise test), ICS: inhaled corticosteroids, SABA: short acting
beta2agonists.
doi:10.1371/journal.pone.0157158.g004
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We found many clinically relevant improvements in asthma features and lung function vari-
ables (including FEV1% predicted, FVC% predicted, asthma control and asthma-related QOL)
in both the intervention and control group. The only variable that improved significantly more
in the intervention group was FVC% predicted. The improvement in FEV1 and FVC in the
intervention group was approximately 10% which is substantial and clinically meaningful.
Moreover, there was a non-significant trend towards more improvement in asthma-related
QOL in the intervention group compared to the control group. Our promising findings of posi-
tive effects of weight reduction on asthma parameters are supported by previous (mostly small
and non-controlled) studies, that demonstrated small though relevant improvements in
asthma-related QOL, asthma control, lung function indices and EIB after weight reduction
[10–13].
How can we explain the lack of contrast between the intervention and control group? Usu-
ally, children with overweight and obesity do not decrease, but increase their BMI-SDS over
time [7]. Most likely, the control group was motivated to lose weight because of the extra atten-
tion and perceived awareness of the problem and the participation in the study [31, 32]. This is
reflected in the large number of participants who arranged professional help for weight reduc-
tion during the study period. It was not possible to blind the study. We did a lot to stimulate
intervention adherence in the intervention group, including imbursements for children when
they reached their personal goals, additional social bonding activities, and regular evaluations.
This was to some extent successful. The average presence for sport, group, parental and indi-
vidual sessions was good, and the average heart rate for each sport session was 79% of the max-
imum heart rate. However, 24 participants did not complete the entire intervention (Fig 1),
and the majority of the discontinuers (63%) stopped during the initial six months of the inter-
vention. In a follow-up study, we (qualitatively) analysed the reasons for non-compliance in
interviews with both children and caregivers. In those interviews, it was often reported that the
high intensity of the programme was difficult to combine with daily life routines, despite
numerous efforts of the researchers to adjust time schedules. Based on this experience, our
advice for future studies is to include the intervention in a daily routine, such as a school envi-
ronment, to avoid non-compliance.
The question arises as to whether the lung function improvements could be attributed to
improvements in BMI-SDS, and/or mechanical and inflammatory changes. We performed a
post-hoc analysis (independent of group allocation), to investigate whether changes in asthma
features (FEV1% predicted, FVC% predicted and asthma control) were associated with changes
in BMI-SDS, changes in leptin or changes in a marker of the mechanical pathway (ERV% pre-
dicted) (S4 File. Post hoc analyses). We found that changes over time in either BMI-SDS, leptin
and ERV% predicted were not related to changes in FEV1% predicted, FVC% predicted, or
asthma control in the group as a whole. This may be a consequence of the small changes of
BMI-SDS in children over time. When analysed cross-sectionally, we detected an association
between more severe asthma features (including low FEV1% predicted and FVC% predicted),
and a high BMI-SDS and low ERV% predicted. Moreover, an association was found between a
marker of the mechanical pathway (low ERV% predicted), but not the inflammatory pathway
(leptin) with lower lung functions in overweight/obese children. This implies that children
with the most severe obesity have altered mechanical markers, and more severe asthma
features.
This study has several methodological strengths [16]: 1) This is a weight reduction study in
overweight/obese children with asthma with an RCT design; 2) a considerable number of chil-
dren (n = 87); 3) a long-term intervention spanning 18 months; 4) outcome measures of both
the inflammatory and mechanical pathways.
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In addition to these strengths, potential limitations can be mentioned. For the study we
included both children with asthma as well as children with overweight/obesity and a family
history of asthma. The latter group was included as these children are at a high risk of develop-
ing asthma and frequently have respiratory symptoms. Therefore we hypothesised that this
group could also benefit from a weight loss intervention. However, this heterogeneity in the
study population could have diluted the results and might be considered to be a limitation of
the study.). However, we believe that the influence on results is limited in our intervention as
outcome parameters such as asthma control and PAQLQ were only determined in the children
with asthma. For future studies, a more homogeneous patient population or separate analyses
(which our sample size did not allow) of these patient categories is advised, though the study in
both groups is relevant as children with overweight/obesity with a high risk of developing
asthma can also benefit from weight reduction interventions.
What are the clinical implications of this study? It is evident from this study that the trend
towards an increase in weight/BMI can be reversed in overweight/obesity children with (a high
risk of developing) asthma, although the lack of contrast between the intervention and control
group is somewhat disappointing. Decreases in body weight and BMI in the children were
accompanied by clinically relevant improvements in all lung function indices, asthma control,
aerobic fitness, and asthma-related quality of life. Another point of interest is the underlying
mechanism of the asthma-obesity relationship. In our population we reported a weak associa-
tion between a marker of the mechanical pathway (ERV% predicted) with BMI-SDS, but no
association between a marker of the inflammatory pathway (leptin) with BMI-SDS. In order to
avoid the trend in the control group that parents/children look for weight reduction measures,
a randomized consent design may be more appropriate for future RCTs on this topic [33].
In summary, this 18-month study on weight reduction shows that overweight/obese children
with (a high risk of developing) asthma decreased in body weight and BMI-SDS, and demon-
strated clinically meaningful improvements in all lung function indices (FEV1, FVC, ERV, TLC),
asthma control, aerobic fitness, and asthma quality of life (PAQLQ), although improvements were
generally no greater in the intervention than in the control group. Only FVC% predicted improved
significantly more in the intervention group compared to the control group, and improvements in
asthma control and asthma related quality of life were more pronounced in the intervention group
than in the control group. We found some indications for the ‘mechanical pathway’ as an underly-
ing mechanism for the improvement in asthma parameters after weight loss.
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